JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3901
MasterCraft Boat Holdings
MCFT
$483M
| $408K | ﹤0.01% |
16,217
+12,248
| +309% | +$296K |
2017 Q4
1 quarter
|
|
|
CSF
3902
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
| $408K | ﹤0.01% |
9,206
+1,853
| +25% | +$83.6K |
2017 Q4
1 quarter
|
|
3903
Dorchester Minerals
DMLP
$1.4B
| $407K | ﹤0.01% |
25,292
+22,542
| +820% | +$357K |
2013 Q2
19 quarters
|
|
|
NOA
3904
North American Construction
NOA
$326M
| $407K | ﹤0.01% |
76,700
+7,300
| +11% | +$36.3K |
2017 Q2
3 quarters
|
|
3905
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.1B
| $407K | ﹤0.01% |
3,144
+31
| +1% | +$4.07K |
2015 Q4
9 quarters
|
|
3906
The RMR Group
RMR
$308M
| $406K | ﹤0.01% |
5,811
+954
| +20% | +$61.4K |
2015 Q4
9 quarters
|
|
3907
Renasant Corp
RNST
$3.59B
| $406K | ﹤0.01% |
9,543
-593
| -6% | -$25.5K |
2016 Q4
5 quarters
|
|
|
RYZ
3908
Ryerson Holding Corp
RYZ
$1.27B
| $406K | ﹤0.01% |
49,720
-30,492
| -38% | -$315K |
2016 Q1
8 quarters
|
|
3909
IMAX
IMAX
$2.88B
| $404K | ﹤0.01% |
21,035
+2,073
| +11% | +$43.1K |
2014 Q2
15 quarters
|
|
3910
Visteon
VC
$2.36B
| $404K | ﹤0.01% |
3,662
-199,397
| -98% | -$24.9M |
2013 Q2
19 quarters
|
|
|
WTPI
3911
WisdomTree Equity Premium Income Fund
WTPI
$541M
| $404K | ﹤0.01% |
14,300
+300
| +2% | +$8.63K |
2017 Q4
1 quarter
|
|
|
HIO
3912
Western Asset High Income Opportunity Fund
HIO
$311M
| $403K | ﹤0.01% |
83,681
-4,600
| -5% | -$22.7K |
2016 Q4
5 quarters
|
|
3913
Invesco Preferred ETF
PGX
$3.63B
| $402K | ﹤0.01% |
27,553
+4,531
| +20% | +$66K |
2014 Q4
13 quarters
|
|
3914
B2Gold
BTG
$6.83B
| $400K | ﹤0.01% |
146,588
-375,780
| -72% | -$1.11M |
2013 Q2
19 quarters
|
|
3915
iShares Dow Jones US ETF
IYY
$3.03B
| $400K | ﹤0.01% |
6,060
-7,028
| -54% | -$480K |
2013 Q2
19 quarters
|
|
|
MTEM
3916
DELISTED
Molecular Templates, Inc.
MTEM
| $400K | ﹤0.01% |
3,335
+976
| +41% | +$147K |
2017 Q3
2 quarters
|
|
3917
MiMedx Group
MDXG
$677M
| $398K | ﹤0.01% |
57,142
-10,505
| -16% | -$122K |
2015 Q4
9 quarters
|
|
|
NPTN
3918
DELISTED
NEOPHOTONICS CORP
NPTN
| $395K | ﹤0.01% |
57,695
+47,836
| +485% | +$304K |
2017 Q4
1 quarter
|
|
|
CNXM
3919
DELISTED
CNX Midstream Partners LP
CNXM
| $395K | ﹤0.01% |
21,465
+9,584
| +81% | +$182K |
2014 Q3
14 quarters
|
|
|
CORV
3920
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $395K | ﹤0.01% |
170,093
+8,643
| +5% | +$13.7K |
2015 Q4
9 quarters
|
|
3921
First Trust Value Line Dividend Fund
FVD
$7.59B
| $394K | ﹤0.01% |
13,168
+1,384
| +12% | +$42.1K |
2015 Q1
12 quarters
|
|
|
KG
3922
Kestrel Group
KG
$38.9M
| $394K | ﹤0.01% |
3,033
-3,003
| -50% | -$417K |
2013 Q2
19 quarters
|
|
|
PMD
3923
DELISTED
Psychemedics Corporation
PMD
| $394K | ﹤0.01% |
19,058
-3,700
| -16% | -$76.8K |
2016 Q3
6 quarters
|
|
|
FBM
3924
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $394K | ﹤0.01% |
26,429
+14,168
| +116% | +$212K |
2017 Q4
1 quarter
|
|
|
AKRX
3925
CALL
DELISTED
Akorn Inc
AKRX
| $393K | ﹤0.01% |
+21,000
| New | +$569K |
2018 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.